当前位置:首页 - 行情中心 - 金河生物(002688) - 财务分析 - 现金流量表

金河生物

(002688)

  

流通市值:36.92亿  总市值:41.28亿
流通股本:7.49亿   总股本:8.37亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,412,113,296.84666,059,534.062,784,871,984.242,041,174,742.37
  收到的税费返还68,820,375.585,615,031.5155,572,559.1448,627,759.69
  收到其他与经营活动有关的现金36,317,924.5410,297,285.4683,655,021.6950,697,958.66
  经营活动现金流入小计1,517,251,596.96681,971,851.032,924,099,565.072,140,500,460.72
  购买商品、接受劳务支付的现金888,008,696.68472,508,084.511,707,952,660.181,241,335,794.24
  支付给职工以及为职工支付的现金242,022,108.52135,576,422.55437,387,757.33306,015,978.89
  支付的各项税费52,932,855.5215,937,181.53113,712,109.2586,090,163.64
  支付其他与经营活动有关的现金80,283,836.7739,315,784.07196,127,508.65142,810,938.39
  经营活动现金流出小计1,263,247,497.49663,337,472.662,455,180,035.411,776,252,875.16
  经营活动产生的现金流量净额254,004,099.4718,634,378.37468,919,529.66364,247,585.56
二、投资活动产生的现金流量:
  收回投资收到的现金6,500,0005,000,000--
  取得投资收益收到的现金20,108.2220,108.22349,500-
  处置固定资产、无形资产和其他长期资产收回的现金净额208,338.8-1,331,638667,030
  收到的其他与投资活动有关的现金--4,000,0004,000,000
  投资活动现金流入小计6,728,447.025,020,108.225,681,1384,667,030
  购建固定资产、无形资产和其他长期资产支付的现金144,128,425.6887,275,331.61320,278,143.93218,199,577.37
  投资活动现金流出小计144,128,425.6887,275,331.61320,278,143.93218,199,577.37
  投资活动产生的现金流量净额-137,399,978.66-82,255,223.39-314,597,005.93-213,532,547.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,350,0002,350,000
  其中:子公司吸收少数股东投资收到的现金---2,350,000
  取得借款收到的现金589,965,306.65553,190,611.831,416,704,972.66925,377,211.55
  收到其他与筹资活动有关的现金315,902,442.3291,994,000204,482,536.01137,232,748.23
  筹资活动现金流入小计905,867,748.95845,184,611.831,623,537,508.671,064,959,959.78
  偿还债务支付的现金674,769,305.26444,429,377.181,425,604,210.11,045,865,317.98
  分配股利、利润或偿付利息支付的现金106,264,952.8516,594,975.46147,846,002.66130,142,732.28
  支付其他与筹资活动有关的现金148,521,900.4599,111,777.45173,610,519.23107,594,110.66
  筹资活动现金流出小计929,556,158.56560,136,130.091,747,060,731.991,283,602,160.92
  筹资活动产生的现金流量净额-23,688,409.61285,048,481.74-123,523,223.32-218,642,201.14
四、汇率变动对现金及现金等价物的影响-7,905,022.85-482,447.91-4,070,922.05-763,289.29
五、现金及现金等价物净增加额85,010,688.35220,945,188.8126,728,378.36-68,690,452.24
  加:期初现金及现金等价物余额615,076,468.06615,076,468.06588,348,089.7588,348,089.7
  期末现金及现金等价物余额700,087,156.41836,021,656.87615,076,468.06519,657,637.46
补充资料:
  净利润135,176,895.88--10,984,967.97-
  资产减值准备8,488,485.09-198,029,714.86-
  固定资产和投资性房地产折旧105,276,029.14-190,882,221.71-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧105,276,029.14-190,882,221.71-
  无形资产摊销20,484,694.65-39,055,285.93-
  长期待摊费用摊销3,069,460.35-5,988,657.83-
  处置固定资产、无形资产和其他长期资产的损失563,110.41-2,732,354.58-
  固定资产报废损失563,110.41-328,440.76-
  公允价值变动损失404,065.76--229,444.57-
  财务费用41,433,250.62-90,411,993.29-
  投资损失-11,370.72-2,627,928.13-
  递延所得税-4,083,201.1-16,462,398.5-
  其中:递延所得税资产减少-1,121,972.18-20,441,485.46-
    递延所得税负债增加-2,961,228.92--3,979,086.96-
  存货的减少-101,893,947.27--17,690,544.64-
  经营性应收项目的减少14,298,686.16-806,255.68-
  经营性应付项目的增加21,218,686.72--47,358,244.88-
  其他8,037,269.16--11,140,558.63-
  现金的期末余额700,087,156.41-615,076,468.06-
  减:现金的期初余额615,076,468.06-588,348,089.7-
  现金及现金等价物的净增加额85,010,688.35-26,728,378.36-
公告日期2026-08-282026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑